Correlation Between Mydecine Innovations and Lobe Sciences
Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Lobe Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Lobe Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mydecine Innovations Group and Lobe Sciences, you can compare the effects of market volatilities on Mydecine Innovations and Lobe Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Lobe Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Lobe Sciences.
Diversification Opportunities for Mydecine Innovations and Lobe Sciences
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between Mydecine and Lobe is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Lobe Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lobe Sciences and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Lobe Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lobe Sciences has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Lobe Sciences go up and down completely randomly.
Pair Corralation between Mydecine Innovations and Lobe Sciences
Assuming the 90 days horizon Mydecine Innovations is expected to generate 11.46 times less return on investment than Lobe Sciences. But when comparing it to its historical volatility, Mydecine Innovations Group is 7.89 times less risky than Lobe Sciences. It trades about 0.19 of its potential returns per unit of risk. Lobe Sciences is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 1.29 in Lobe Sciences on August 25, 2024 and sell it today you would lose (0.04) from holding Lobe Sciences or give up 3.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mydecine Innovations Group vs. Lobe Sciences
Performance |
| Timeline |
| Mydecine Innovations |
| Lobe Sciences |
Mydecine Innovations and Lobe Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mydecine Innovations and Lobe Sciences
The main advantage of trading using opposite Mydecine Innovations and Lobe Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Lobe Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lobe Sciences will offset losses from the drop in Lobe Sciences' long position.| Mydecine Innovations vs. Green Cures Botanical | Mydecine Innovations vs. Cann American Corp | Mydecine Innovations vs. Rimrock Gold Corp | Mydecine Innovations vs. Galexxy Holdings |
| Lobe Sciences vs. Green Cures Botanical | Lobe Sciences vs. Galexxy Holdings | Lobe Sciences vs. Indoor Harvest Corp | Lobe Sciences vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |